nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Tamoxifen—pancreatic cancer	0.0857	0.16	CbGbCtD
Dolasetron—CYP2D6—Tamoxifen—pancreatic cancer	0.0784	0.147	CbGbCtD
Dolasetron—CYP2D6—Erlotinib—pancreatic cancer	0.0666	0.125	CbGbCtD
Dolasetron—HTR3A—enteric nervous system—pancreatic cancer	0.0643	0.817	CbGeAlD
Dolasetron—CYP2C9—Fluorouracil—pancreatic cancer	0.0632	0.118	CbGbCtD
Dolasetron—CYP3A4—Tamoxifen—pancreatic cancer	0.0498	0.0933	CbGbCtD
Dolasetron—CYP3A4—Erlotinib—pancreatic cancer	0.0424	0.0793	CbGbCtD
Dolasetron—CYP3A4—Irinotecan—pancreatic cancer	0.0383	0.0717	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—pancreatic cancer	0.0329	0.0616	CbGbCtD
Dolasetron—CYP3A4—Docetaxel—pancreatic cancer	0.028	0.0525	CbGbCtD
Dolasetron—CYP3A4—Sunitinib—pancreatic cancer	0.0279	0.0523	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—pancreatic cancer	0.0209	0.0391	CbGbCtD
Dolasetron—HTR3A—islet of Langerhans—pancreatic cancer	0.00615	0.0781	CbGeAlD
Dolasetron—HTR3A—digestive system—pancreatic cancer	0.00369	0.0469	CbGeAlD
Dolasetron—CYP2C9—digestive system—pancreatic cancer	0.00181	0.023	CbGeAlD
Dolasetron—CYP3A4—digestive system—pancreatic cancer	0.00138	0.0175	CbGeAlD
Dolasetron—CYP2D6—digestive system—pancreatic cancer	0.00136	0.0172	CbGeAlD
Dolasetron—Dermatitis—Tamoxifen—pancreatic cancer	0.000484	0.00125	CcSEcCtD
Dolasetron—Ataxia—Epirubicin—pancreatic cancer	0.000483	0.00125	CcSEcCtD
Dolasetron—Dyspnoea—Irinotecan—pancreatic cancer	0.000483	0.00125	CcSEcCtD
Dolasetron—Somnolence—Irinotecan—pancreatic cancer	0.000482	0.00124	CcSEcCtD
Dolasetron—Headache—Tamoxifen—pancreatic cancer	0.000481	0.00124	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000481	0.00124	CcSEcCtD
Dolasetron—Rash—Erlotinib—pancreatic cancer	0.000479	0.00124	CcSEcCtD
Dolasetron—Dermatitis—Erlotinib—pancreatic cancer	0.000479	0.00124	CcSEcCtD
Dolasetron—Dehydration—Epirubicin—pancreatic cancer	0.000478	0.00123	CcSEcCtD
Dolasetron—Dyspepsia—Irinotecan—pancreatic cancer	0.000477	0.00123	CcSEcCtD
Dolasetron—Headache—Erlotinib—pancreatic cancer	0.000476	0.00123	CcSEcCtD
Dolasetron—Paraesthesia—Gemcitabine—pancreatic cancer	0.000474	0.00122	CcSEcCtD
Dolasetron—Chills—Docetaxel—pancreatic cancer	0.000473	0.00122	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000473	0.00122	CcSEcCtD
Dolasetron—Asthenia—Sunitinib—pancreatic cancer	0.000472	0.00122	CcSEcCtD
Dolasetron—Decreased appetite—Irinotecan—pancreatic cancer	0.000471	0.00122	CcSEcCtD
Dolasetron—Arrhythmia—Docetaxel—pancreatic cancer	0.000471	0.00122	CcSEcCtD
Dolasetron—Dyspnoea—Gemcitabine—pancreatic cancer	0.000471	0.00122	CcSEcCtD
Dolasetron—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00047	0.00121	CcSEcCtD
Dolasetron—Somnolence—Gemcitabine—pancreatic cancer	0.000469	0.00121	CcSEcCtD
Dolasetron—Fatigue—Irinotecan—pancreatic cancer	0.000467	0.00121	CcSEcCtD
Dolasetron—Paraesthesia—Fluorouracil—pancreatic cancer	0.000466	0.0012	CcSEcCtD
Dolasetron—Pruritus—Sunitinib—pancreatic cancer	0.000465	0.0012	CcSEcCtD
Dolasetron—Constipation—Irinotecan—pancreatic cancer	0.000463	0.0012	CcSEcCtD
Dolasetron—Pain—Irinotecan—pancreatic cancer	0.000463	0.0012	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000463	0.0012	CcSEcCtD
Dolasetron—Dyspnoea—Fluorouracil—pancreatic cancer	0.000463	0.0012	CcSEcCtD
Dolasetron—Somnolence—Fluorouracil—pancreatic cancer	0.000461	0.00119	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—pancreatic cancer	0.000459	0.00119	CcSEcCtD
Dolasetron—Decreased appetite—Gemcitabine—pancreatic cancer	0.000459	0.00119	CcSEcCtD
Dolasetron—Dyspepsia—Fluorouracil—pancreatic cancer	0.000457	0.00118	CcSEcCtD
Dolasetron—Fatigue—Gemcitabine—pancreatic cancer	0.000455	0.00118	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000453	0.00117	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000452	0.00117	CcSEcCtD
Dolasetron—Pain—Gemcitabine—pancreatic cancer	0.000451	0.00117	CcSEcCtD
Dolasetron—Constipation—Gemcitabine—pancreatic cancer	0.000451	0.00117	CcSEcCtD
Dolasetron—Decreased appetite—Fluorouracil—pancreatic cancer	0.000451	0.00117	CcSEcCtD
Dolasetron—Diarrhoea—Sunitinib—pancreatic cancer	0.00045	0.00116	CcSEcCtD
Dolasetron—Dysgeusia—Docetaxel—pancreatic cancer	0.000449	0.00116	CcSEcCtD
Dolasetron—Abdominal distension—Epirubicin—pancreatic cancer	0.000447	0.00116	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—pancreatic cancer	0.000447	0.00116	CcSEcCtD
Dolasetron—Feeling abnormal—Irinotecan—pancreatic cancer	0.000447	0.00115	CcSEcCtD
Dolasetron—Pain—Fluorouracil—pancreatic cancer	0.000444	0.00115	CcSEcCtD
Dolasetron—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000443	0.00114	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—pancreatic cancer	0.000442	0.00114	CcSEcCtD
Dolasetron—Pancreatitis—Epirubicin—pancreatic cancer	0.000436	0.00113	CcSEcCtD
Dolasetron—Dizziness—Sunitinib—pancreatic cancer	0.000435	0.00112	CcSEcCtD
Dolasetron—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000435	0.00112	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000434	0.00112	CcSEcCtD
Dolasetron—Abdominal pain—Irinotecan—pancreatic cancer	0.000428	0.00111	CcSEcCtD
Dolasetron—Body temperature increased—Irinotecan—pancreatic cancer	0.000428	0.00111	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000428	0.00111	CcSEcCtD
Dolasetron—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000428	0.0011	CcSEcCtD
Dolasetron—Anaemia—Docetaxel—pancreatic cancer	0.000424	0.0011	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.00042	0.00108	CcSEcCtD
Dolasetron—Body temperature increased—Gemcitabine—pancreatic cancer	0.000417	0.00108	CcSEcCtD
Dolasetron—Dysuria—Epirubicin—pancreatic cancer	0.000415	0.00107	CcSEcCtD
Dolasetron—Rash—Sunitinib—pancreatic cancer	0.000415	0.00107	CcSEcCtD
Dolasetron—Dermatitis—Sunitinib—pancreatic cancer	0.000414	0.00107	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—pancreatic cancer	0.000414	0.00107	CcSEcCtD
Dolasetron—Urticaria—Fluorouracil—pancreatic cancer	0.000412	0.00107	CcSEcCtD
Dolasetron—Headache—Sunitinib—pancreatic cancer	0.000412	0.00106	CcSEcCtD
Dolasetron—Syncope—Docetaxel—pancreatic cancer	0.000412	0.00106	CcSEcCtD
Dolasetron—Body temperature increased—Fluorouracil—pancreatic cancer	0.00041	0.00106	CcSEcCtD
Dolasetron—Palpitations—Docetaxel—pancreatic cancer	0.000406	0.00105	CcSEcCtD
Dolasetron—Loss of consciousness—Docetaxel—pancreatic cancer	0.000403	0.00104	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—pancreatic cancer	0.000403	0.00104	CcSEcCtD
Dolasetron—Cough—Docetaxel—pancreatic cancer	0.000401	0.00103	CcSEcCtD
Dolasetron—Hypersensitivity—Irinotecan—pancreatic cancer	0.000399	0.00103	CcSEcCtD
Dolasetron—Pneumonia—Epirubicin—pancreatic cancer	0.000398	0.00103	CcSEcCtD
Dolasetron—Convulsion—Docetaxel—pancreatic cancer	0.000398	0.00103	CcSEcCtD
Dolasetron—Hypertension—Docetaxel—pancreatic cancer	0.000396	0.00102	CcSEcCtD
Dolasetron—Drowsiness—Epirubicin—pancreatic cancer	0.000396	0.00102	CcSEcCtD
Dolasetron—Arthralgia—Docetaxel—pancreatic cancer	0.000391	0.00101	CcSEcCtD
Dolasetron—Myalgia—Docetaxel—pancreatic cancer	0.000391	0.00101	CcSEcCtD
Dolasetron—Chest pain—Docetaxel—pancreatic cancer	0.000391	0.00101	CcSEcCtD
Dolasetron—Asthenia—Irinotecan—pancreatic cancer	0.000389	0.001	CcSEcCtD
Dolasetron—Jaundice—Epirubicin—pancreatic cancer	0.000386	0.000997	CcSEcCtD
Dolasetron—Stomatitis—Epirubicin—pancreatic cancer	0.000386	0.000997	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—pancreatic cancer	0.000384	0.000993	CcSEcCtD
Dolasetron—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000382	0.000988	CcSEcCtD
Dolasetron—Dry mouth—Docetaxel—pancreatic cancer	0.000382	0.000987	CcSEcCtD
Dolasetron—Asthenia—Gemcitabine—pancreatic cancer	0.000379	0.000978	CcSEcCtD
Dolasetron—Haematuria—Epirubicin—pancreatic cancer	0.000378	0.000976	CcSEcCtD
Dolasetron—Confusional state—Docetaxel—pancreatic cancer	0.000378	0.000976	CcSEcCtD
Dolasetron—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000375	0.000968	CcSEcCtD
Dolasetron—Oedema—Docetaxel—pancreatic cancer	0.000375	0.000968	CcSEcCtD
Dolasetron—Epistaxis—Epirubicin—pancreatic cancer	0.000374	0.000965	CcSEcCtD
Dolasetron—Pruritus—Gemcitabine—pancreatic cancer	0.000373	0.000965	CcSEcCtD
Dolasetron—Diarrhoea—Irinotecan—pancreatic cancer	0.000371	0.000958	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—pancreatic cancer	0.000369	0.000952	CcSEcCtD
Dolasetron—Shock—Docetaxel—pancreatic cancer	0.000369	0.000952	CcSEcCtD
Dolasetron—Pruritus—Fluorouracil—pancreatic cancer	0.000367	0.000948	CcSEcCtD
Dolasetron—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000367	0.000947	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—pancreatic cancer	0.000367	0.000947	CcSEcCtD
Dolasetron—Tachycardia—Docetaxel—pancreatic cancer	0.000366	0.000944	CcSEcCtD
Dolasetron—Bradycardia—Epirubicin—pancreatic cancer	0.000362	0.000935	CcSEcCtD
Dolasetron—Diarrhoea—Gemcitabine—pancreatic cancer	0.000361	0.000933	CcSEcCtD
Dolasetron—Dizziness—Irinotecan—pancreatic cancer	0.000358	0.000926	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—pancreatic cancer	0.000357	0.000923	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—pancreatic cancer	0.000357	0.000923	CcSEcCtD
Dolasetron—Anorexia—Docetaxel—pancreatic cancer	0.000357	0.000922	CcSEcCtD
Dolasetron—Diarrhoea—Fluorouracil—pancreatic cancer	0.000355	0.000917	CcSEcCtD
Dolasetron—Oedema peripheral—Epirubicin—pancreatic cancer	0.00035	0.000905	CcSEcCtD
Dolasetron—Hypotension—Docetaxel—pancreatic cancer	0.00035	0.000904	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—pancreatic cancer	0.00035	0.000903	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—pancreatic cancer	0.000346	0.000893	CcSEcCtD
Dolasetron—Dizziness—Fluorouracil—pancreatic cancer	0.000343	0.000887	CcSEcCtD
Dolasetron—Visual impairment—Epirubicin—pancreatic cancer	0.000343	0.000885	CcSEcCtD
Dolasetron—Rash—Irinotecan—pancreatic cancer	0.000342	0.000883	CcSEcCtD
Dolasetron—Dermatitis—Irinotecan—pancreatic cancer	0.000341	0.000882	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000341	0.000882	CcSEcCtD
Dolasetron—Headache—Irinotecan—pancreatic cancer	0.000339	0.000877	CcSEcCtD
Dolasetron—Paraesthesia—Docetaxel—pancreatic cancer	0.000336	0.000869	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—pancreatic cancer	0.000335	0.000865	CcSEcCtD
Dolasetron—Dyspnoea—Docetaxel—pancreatic cancer	0.000334	0.000863	CcSEcCtD
Dolasetron—Somnolence—Docetaxel—pancreatic cancer	0.000333	0.00086	CcSEcCtD
Dolasetron—Rash—Gemcitabine—pancreatic cancer	0.000333	0.00086	CcSEcCtD
Dolasetron—Dermatitis—Gemcitabine—pancreatic cancer	0.000333	0.000859	CcSEcCtD
Dolasetron—Tinnitus—Epirubicin—pancreatic cancer	0.000332	0.000857	CcSEcCtD
Dolasetron—Headache—Gemcitabine—pancreatic cancer	0.000331	0.000854	CcSEcCtD
Dolasetron—Flushing—Epirubicin—pancreatic cancer	0.00033	0.000853	CcSEcCtD
Dolasetron—Dyspepsia—Docetaxel—pancreatic cancer	0.00033	0.000852	CcSEcCtD
Dolasetron—Rash—Fluorouracil—pancreatic cancer	0.000327	0.000845	CcSEcCtD
Dolasetron—Dermatitis—Fluorouracil—pancreatic cancer	0.000327	0.000845	CcSEcCtD
Dolasetron—Decreased appetite—Docetaxel—pancreatic cancer	0.000326	0.000841	CcSEcCtD
Dolasetron—Headache—Fluorouracil—pancreatic cancer	0.000325	0.00084	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000324	0.000837	CcSEcCtD
Dolasetron—Fatigue—Docetaxel—pancreatic cancer	0.000323	0.000834	CcSEcCtD
Dolasetron—Pain—Docetaxel—pancreatic cancer	0.00032	0.000827	CcSEcCtD
Dolasetron—Constipation—Docetaxel—pancreatic cancer	0.00032	0.000827	CcSEcCtD
Dolasetron—Chills—Epirubicin—pancreatic cancer	0.000319	0.000824	CcSEcCtD
Dolasetron—Arrhythmia—Epirubicin—pancreatic cancer	0.000318	0.000821	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—pancreatic cancer	0.000317	0.000819	CcSEcCtD
Dolasetron—Feeling abnormal—Docetaxel—pancreatic cancer	0.000309	0.000797	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—pancreatic cancer	0.000307	0.000793	CcSEcCtD
Dolasetron—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000306	0.000791	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—pancreatic cancer	0.000305	0.000789	CcSEcCtD
Dolasetron—Flatulence—Epirubicin—pancreatic cancer	0.000305	0.000788	CcSEcCtD
Dolasetron—Dysgeusia—Epirubicin—pancreatic cancer	0.000303	0.000783	CcSEcCtD
Dolasetron—Abdominal pain—Docetaxel—pancreatic cancer	0.000296	0.000765	CcSEcCtD
Dolasetron—Body temperature increased—Docetaxel—pancreatic cancer	0.000296	0.000765	CcSEcCtD
Dolasetron—Chills—Doxorubicin—pancreatic cancer	0.000295	0.000763	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—pancreatic cancer	0.000294	0.000759	CcSEcCtD
Dolasetron—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000287	0.000742	CcSEcCtD
Dolasetron—Anaemia—Epirubicin—pancreatic cancer	0.000286	0.000739	CcSEcCtD
Dolasetron—Agitation—Epirubicin—pancreatic cancer	0.000285	0.000735	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—pancreatic cancer	0.000282	0.000729	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—pancreatic cancer	0.000281	0.000725	CcSEcCtD
Dolasetron—Malaise—Epirubicin—pancreatic cancer	0.000279	0.000721	CcSEcCtD
Dolasetron—Vertigo—Epirubicin—pancreatic cancer	0.000278	0.000718	CcSEcCtD
Dolasetron—Syncope—Epirubicin—pancreatic cancer	0.000278	0.000717	CcSEcCtD
Dolasetron—Hypersensitivity—Docetaxel—pancreatic cancer	0.000276	0.000713	CcSEcCtD
Dolasetron—Palpitations—Epirubicin—pancreatic cancer	0.000274	0.000707	CcSEcCtD
Dolasetron—Loss of consciousness—Epirubicin—pancreatic cancer	0.000272	0.000703	CcSEcCtD
Dolasetron—Cough—Epirubicin—pancreatic cancer	0.00027	0.000698	CcSEcCtD
Dolasetron—Asthenia—Docetaxel—pancreatic cancer	0.000269	0.000694	CcSEcCtD
Dolasetron—Convulsion—Epirubicin—pancreatic cancer	0.000268	0.000693	CcSEcCtD
Dolasetron—Hypertension—Epirubicin—pancreatic cancer	0.000267	0.00069	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000266	0.000687	CcSEcCtD
Dolasetron—Pruritus—Docetaxel—pancreatic cancer	0.000265	0.000685	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—pancreatic cancer	0.000265	0.000684	CcSEcCtD
Dolasetron—Arthralgia—Epirubicin—pancreatic cancer	0.000264	0.000681	CcSEcCtD
Dolasetron—Myalgia—Epirubicin—pancreatic cancer	0.000264	0.000681	CcSEcCtD
Dolasetron—Chest pain—Epirubicin—pancreatic cancer	0.000264	0.000681	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—pancreatic cancer	0.000263	0.00068	CcSEcCtD
Dolasetron—Anxiety—Epirubicin—pancreatic cancer	0.000263	0.000678	CcSEcCtD
Dolasetron—Discomfort—Epirubicin—pancreatic cancer	0.00026	0.000673	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—pancreatic cancer	0.000258	0.000667	CcSEcCtD
Dolasetron—Dry mouth—Epirubicin—pancreatic cancer	0.000258	0.000666	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—pancreatic cancer	0.000257	0.000665	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—pancreatic cancer	0.000257	0.000664	CcSEcCtD
Dolasetron—Diarrhoea—Docetaxel—pancreatic cancer	0.000256	0.000662	CcSEcCtD
Dolasetron—Confusional state—Epirubicin—pancreatic cancer	0.000255	0.000658	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—pancreatic cancer	0.000253	0.000654	CcSEcCtD
Dolasetron—Oedema—Epirubicin—pancreatic cancer	0.000253	0.000653	CcSEcCtD
Dolasetron—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000253	0.000653	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000252	0.00065	CcSEcCtD
Dolasetron—Cough—Doxorubicin—pancreatic cancer	0.00025	0.000646	CcSEcCtD
Dolasetron—Shock—Epirubicin—pancreatic cancer	0.000249	0.000642	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—pancreatic cancer	0.000248	0.000641	CcSEcCtD
Dolasetron—Dizziness—Docetaxel—pancreatic cancer	0.000248	0.00064	CcSEcCtD
Dolasetron—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000247	0.000639	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—pancreatic cancer	0.000247	0.000639	CcSEcCtD
Dolasetron—Tachycardia—Epirubicin—pancreatic cancer	0.000247	0.000637	CcSEcCtD
Dolasetron—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000244	0.000631	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—pancreatic cancer	0.000244	0.00063	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—pancreatic cancer	0.000244	0.00063	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—pancreatic cancer	0.000244	0.00063	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—pancreatic cancer	0.000243	0.000628	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—pancreatic cancer	0.000241	0.000622	CcSEcCtD
Dolasetron—Anorexia—Epirubicin—pancreatic cancer	0.000241	0.000622	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—pancreatic cancer	0.000239	0.000616	CcSEcCtD
Dolasetron—Rash—Docetaxel—pancreatic cancer	0.000236	0.00061	CcSEcCtD
Dolasetron—Hypotension—Epirubicin—pancreatic cancer	0.000236	0.00061	CcSEcCtD
Dolasetron—Dermatitis—Docetaxel—pancreatic cancer	0.000236	0.00061	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—pancreatic cancer	0.000236	0.000609	CcSEcCtD
Dolasetron—Headache—Docetaxel—pancreatic cancer	0.000235	0.000606	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000234	0.000604	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—pancreatic cancer	0.000234	0.000604	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00023	0.000595	CcSEcCtD
Dolasetron—Shock—Doxorubicin—pancreatic cancer	0.00023	0.000594	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000229	0.000591	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—pancreatic cancer	0.000228	0.000589	CcSEcCtD
Dolasetron—Paraesthesia—Epirubicin—pancreatic cancer	0.000227	0.000586	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000226	0.000584	CcSEcCtD
Dolasetron—Dyspnoea—Epirubicin—pancreatic cancer	0.000225	0.000582	CcSEcCtD
Dolasetron—Somnolence—Epirubicin—pancreatic cancer	0.000225	0.00058	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—pancreatic cancer	0.000223	0.000576	CcSEcCtD
Dolasetron—Dyspepsia—Epirubicin—pancreatic cancer	0.000222	0.000575	CcSEcCtD
Dolasetron—Decreased appetite—Epirubicin—pancreatic cancer	0.00022	0.000567	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—pancreatic cancer	0.000218	0.000564	CcSEcCtD
Dolasetron—Fatigue—Epirubicin—pancreatic cancer	0.000218	0.000563	CcSEcCtD
Dolasetron—Pain—Epirubicin—pancreatic cancer	0.000216	0.000558	CcSEcCtD
Dolasetron—Constipation—Epirubicin—pancreatic cancer	0.000216	0.000558	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000213	0.00055	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—pancreatic cancer	0.00021	0.000542	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—pancreatic cancer	0.000208	0.000538	CcSEcCtD
Dolasetron—Feeling abnormal—Epirubicin—pancreatic cancer	0.000208	0.000538	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—pancreatic cancer	0.000208	0.000537	CcSEcCtD
Dolasetron—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000207	0.000534	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—pancreatic cancer	0.000206	0.000532	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—pancreatic cancer	0.000203	0.000525	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—pancreatic cancer	0.000202	0.000521	CcSEcCtD
Dolasetron—Urticaria—Epirubicin—pancreatic cancer	0.000201	0.000518	CcSEcCtD
Dolasetron—Pain—Doxorubicin—pancreatic cancer	0.0002	0.000516	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—pancreatic cancer	0.0002	0.000516	CcSEcCtD
Dolasetron—Abdominal pain—Epirubicin—pancreatic cancer	0.0002	0.000516	CcSEcCtD
Dolasetron—Body temperature increased—Epirubicin—pancreatic cancer	0.0002	0.000516	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000193	0.000498	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000191	0.000494	CcSEcCtD
Dolasetron—Hypersensitivity—Epirubicin—pancreatic cancer	0.000186	0.000481	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—pancreatic cancer	0.000186	0.00048	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—pancreatic cancer	0.000185	0.000477	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—pancreatic cancer	0.000185	0.000477	CcSEcCtD
Dolasetron—Asthenia—Epirubicin—pancreatic cancer	0.000181	0.000468	CcSEcCtD
Dolasetron—Pruritus—Epirubicin—pancreatic cancer	0.000179	0.000462	CcSEcCtD
Dolasetron—Diarrhoea—Epirubicin—pancreatic cancer	0.000173	0.000447	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000172	0.000445	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—pancreatic cancer	0.000168	0.000433	CcSEcCtD
Dolasetron—Dizziness—Epirubicin—pancreatic cancer	0.000167	0.000432	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—pancreatic cancer	0.000165	0.000427	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—pancreatic cancer	0.00016	0.000413	CcSEcCtD
Dolasetron—Rash—Epirubicin—pancreatic cancer	0.000159	0.000412	CcSEcCtD
Dolasetron—Dermatitis—Epirubicin—pancreatic cancer	0.000159	0.000411	CcSEcCtD
Dolasetron—Headache—Epirubicin—pancreatic cancer	0.000158	0.000409	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—pancreatic cancer	0.000155	0.000399	CcSEcCtD
Dolasetron—Rash—Doxorubicin—pancreatic cancer	0.000147	0.000381	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—pancreatic cancer	0.000147	0.00038	CcSEcCtD
Dolasetron—Headache—Doxorubicin—pancreatic cancer	0.000146	0.000378	CcSEcCtD
